Catalyst Event
Sanofi (SNY) · Other
From KEDI Tesla Fixed Tech100 Index (KTSLT100)
6/8/2026, 12:00:00 AM
The European Commission approved a subcutaneous formulation of Sarclisa (isatuximab) for multiple myeloma, administered via an on-body injector, expanding treatment options.
Korean Translation
유럽연합 집행위원회, 다발성 골수종 치료제 사클리사(Sarclisa)의 피하주사 제형(온바디 인젝터 방식)을 승인함
Related Recent Events
Applied Materials Inc (AMAT) · Earnings Release
Applied Materials is expected to announce its Q3 2026 fiscal year earnings on August 13, 2026. The company previously guided for revenue of approximately $8.95 billion and non-GAAP EPS of $3.36, which would represent significant year-over-year growth. High importance is assigned as earnings releases for major semiconductor firms typically drive significant market volatility. This is scheduled.
8/13/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Q2 2026 earnings release on August 6, 2026, is scheduled; analysts forecast an EPS of approximately -$0.07. Medium importance is estimated as earnings releases typically trigger significant price movement, forecasted.
8/6/2026, 12:00:00 AM
Datadog Inc (DDOG) · Earnings Release
Datadog is scheduled to announce its Q2 2026 financial results on August 6, 2026; market impact estimated at <5% until actual results are released, expected.
8/6/2026, 12:00:00 AM
Fortinet Inc (FTNT) · Earnings Release
Fortinet's Q2 2026 earnings release is scheduled.
8/5/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Advanced Micro Devices is expected to release its Q2 2026 earnings results on August 4, 2026; analysts forecast revenue of $11.25 billion and EPS of $1.55-$1.60. This forecast is estimated to have a ~1% price impact, forecasted.
8/4/2026, 12:00:00 AM
Seagate Technology Holdings plc (STX) · Earnings Release
Low importance estimated as the event has not occurred yet; fiscal Q4 2026 earnings release is expected on August 4, 2026, with analysts forecasting EPS of approximately $5.04 forecasted.
8/4/2026, 12:00:00 AM